Our Partners for 2025

Exhibition Partners:

Logo_Vazyme

Vazyme

Vazyme is a global technology and service provider dedicated to the design, manufacture, and application of bioactive proteins. With outstanding product quality and extensive supply chain expertise, we are driving innovation in T7 polymerases to meet diverse RNA synthesis needs, and are able to self-develop and produce dsRNA residue detection kits. Our GMP grade mRNA tool enzymes and quality control kits ensure safety and efficacy, accelerating mRNA vaccine/drug R&D and advancing projects to clinical trials. 

www.vazymebiotech.com

2017_PromegaLogo_Sol (2)

Promega

Promega is committed to excellence in technologies and compound profiling services to assess key processes in Targeted Protein Degradation and Induced Proximity mechanisms. From assessing protein degradation in real time, to understanding compound binding and permeability, to ternary complex formation and more. Our CRIPSR HiBiT content covers hundreds of pre-built targets. Novel software analysis tools allow for the determination of target protein degradation rates, DC50 potency values, recovery profiles and more.

www.promega.co.uk

GeneTex logo_300dpi_L(1)

GeneTex

GeneTex is a multinational antibody manufacturer with over 25 years of experience generating antibodies for biomedical research. In 2020, the company implemented a high-throughput recombinant monoclonal antibody production platform combined with enhanced validation strategies. Using this approach, GeneTex is focused on creating a best-in-class collection of antibodies targeting the approximately 350 human non-sensory GPCRs with the goal of advancing GPCR research and drug discovery.

www.genetex.com

Event Partner:

Nxera Master Logo RGB Black

Nxera

Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of medicines to improve the lives of patients with unmet needs in Japan and globally. In addition to several products being commercialized in Japan, we’re advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders and rare diseases, leveraging the power of our unique and industry leading GPCR-targeted SBDD NxWave™ platform.
PARTNER WITH US